While being an innovative company doesn’t guarantee superior long-term returns, it doesn’t hurt those chances either. In fact, when a corporation is making important breakthroughs and boasts significant growth prospects in its industry, that could translate to above-average stock market performances over five years or more.
That description fits TransMedics Group (NASDAQ: TMDX) and Exact Sciences (NASDAQ: EXAS), two innovative healthcare leaders. Here’s why these companies could deliver strong returns through the end of the decade.
Image source: Getty Images.